Use of Letermovir as Secondary Prophylaxis in Cytomegalovirus Resistant Pediatric Heart Transplant Recipients.

Cytovene (ganciclovir) - Roche

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/40434959

Debbie-Ann Shirley; Dipankar Gupta; Emily Martin; John-Anthony Coppola; Varvara Probst

May 28, 2025